Answers are grounded in this paper and cite their sources.
This study aimed to identify clinicopathological factors associated with Gleason score upgrading after radical prostatectomy in men diagnosed with biopsy Gleason 6 prostate cancer. Three hundred thirteen patients who underwent radical prostatectomy from 2018/01 to 2024/09 were retrospectively analyzed. We enrolled data on 124 patients who were diagnosed with Gleason 6 prostate cancer after multicore (≥ 12 cores) biopsy and who underwent RP without neoadjuvant treatment. Preoperative clinical and pathological variables were collected and analyzed. Optimal cut-off values were determined using receiver operating characteristic (ROC) curve analysis. Upgrading was observed in 53 patients, whereas 71 patients showed no upgrading after radical prostatectomy. Higher prostate-specific antigen (PSA) levels ( p = 0.019), elevated prostate-specific antigen density (PSAD) ( p = 0.001), and the presence of perineural invasion (PNI) ( p < 0.001) were associated with Gleason score upgrading. In multivariable analysis, elevated PSAD and PNI remained independently associated with upgrading. However, the overall discriminatory performance of PSAD was modest (AUC = 0.680). No statistically significant association was observed between the De-Ritis ratio and Gleason score upgrading ( p = 0.215). In this retrospective cohort of patients with biopsy Gleason 6 prostate cancer undergoing radical prostatectomy, elevated PSAD and the presence of PNI were independently associated with Gleason score upgrading. Although PSAD demonstrated modest predictive performance, it may provide adjunctive information regarding the risk of pathological upgrading when interpreted together with other clinicopathological parameters.
No takes yet. Share an insight, caveat, or question.
Öztürk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: